Product Information
- (2E,4E,7R)-11-[(2R,3R)-3-(Hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-2,4-undecadienoic acid
- (2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid
- 11-[3(R)-(Hydroxymethyl-4-oxooxetan-2(R)-yl]-3,5,7(R)-trimethyl-2(E),4(E)-undecadienoic acid
- 1233A
- 2,4-Undecadienoic acid, 11-[(2R,3R)-3-(hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-, (2E,4E,7R)-
- 2,4-Undecadienoic acid, 11-[3-(hydroxymethyl)-4-oxo-2-oxetanyl]-3,5,7-trimethyl-, [2R-[2α(2E,4E,7R*),3β]]-
- Antibiotic 1233A
- Antibiotic F 244
- F-244
- L-659699
- See more synonyms
Hymeglusin is a broad-spectrum antiviral drug that inhibits the synthesis of proteins in cells. It reversibly inhibits protein synthesis by binding to the hydroxyl group on the fatty acid side chain of eukaryotic elongation factor 2 (eEF2). Hymeglusin has been shown to be effective against hepatitis C virus (HCV) and human immunodeficiency virus (HIV). This compound has also been shown to inhibit the growth of leukemia cells, HL-60 and K562, in a model system.
Chemical properties
Technical inquiry about: 3D-EBA06642 Hymeglusin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.